Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase

Circulation Journal

Volumn 76, Issue 11, 2012, Pages 2497-2512

  Maron, Bradley A ^a,b   Michel, Thomas ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Nitric oxide; Nitric oxide synthase; Reactive oxygen species

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIN B RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE REDUCTASE; GUANYLATE CYCLASE; HEME OXYGENASE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; PEROXIREDOXIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN KINASE B; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; S NITROSOTHIOL; SIRTUIN 1; SUPEROXIDE DISMUTASE; THIOREDOXIN; THIOREDOXIN REDUCTASE; VASCULOTROPIN RECEPTOR 2;

BIOSENSOR; BLOOD VESSEL REACTIVITY; CAVEOLA; CELLULAR DISTRIBUTION; CONCEPTUAL FRAMEWORK; HUMAN; HYPOXIA; NITROSYLATION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; CAVEOLAE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDANTS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84869100949     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1207     Document Type: Review

References (172)

1. Michel T. NO way to relax: The complexities of coupling nitric oxide synthase pathways in the heart. Circulation 2010; 121: 484-486.
2. Bin Q, Hu X, Cao Y, Gao F. The role of vitamin E (tocopherol) supplementation in the prevention of stroke: A meta-analysis of 13 randomised controlled trials. Thromb Haemost 2011; 105: 579-585.
3. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability: Role of arginine metabolism and oxidative stress. Hypertension 2006; 48: 278-285.
4. Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R. An oxidative stress score as a combined measure of the pro-oxidant and antioxidant counterparts in patients with coronary artery disease. Clin Biochem 2008; 41: 1162-1167.
5. Loffredo L, Marcoccia A, Pignatelli P, Andreozzi P, Borgia MC, Cangemi P, et al. Oxidative stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 2007; 28: 608-612.
6. Polonikov A, Vialykh E, Vasil'eva O, Bulgakova I, Bushueva O, Illig T, et al. Genetic variation in glutathione s-transferase genes and risk of nonfatal cerebral stroke in patients suffering from essential hypertension. J Mol Neurosci 2012; 47: 511-513.
7. Voelkel NF, Bogaard HJ, Al Husseini AA, Farkas L, Gomez-Arroyo J, Natarajan R. Antioxidants for the treatment of patients with se vere angioproliferative pulmonary hypertension? Antioxid Redox Signal 2012 August 7 [Epub ahead of print].
8. Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA, Terada LS. Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 2005; 171: 583.
9. Dudzinski DM, Igarashi J, Greif D, Michel T. The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 2006; 46: 235-276.
10. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet 1997; 51: 26-30.
11. Thomas SR, Chen K, Keaney JF. Hydrogen peroxide activates endothelial nitric oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinas-dependent signaling pathway. J Biol Chem 2002; 277: 6017-6024.
12. Dick JM. Calculation of the relative metastabilities of proteins in subcellular compartments of Saccharomyces cerevisia. BMC Syst Biol 2009; 3: 75.
13. Zhang Y, Hogg N. Formation and stability of S-nitrosothiols in RAW 264.7 cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L467-L474.
14. Lambert AJ, Brand MD. Reactive oxygen species production by mitochondria. Methods Mol Biol 2009; 554: 165-181.
15. Mattiasson G. Analysis of mitochondrial generation and release of reactive oxygen species. Cytometry A 2004; 62: 89-96.
16. Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, et al. NOX Activator 1: A potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 2010; 121: 549-559.
17. 2 accumulation for cell signaling. Cell 2010; 140: 517-528.
18. Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, et al. Hypoxia triggers subcellular compartment redox signaling in vascular smooth muscle cells. Circ Res 2010; 106: 526-535.
19. Erwin PA, Mitchell DA, Sartoretto J, Marletta MA, Michel T. Subcellular targeting and differential S-nitrosylation of endothelial nitric oxide synthase. J Biol Chem 2006; 281: 151-157.
20. Hashemy SI, Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 2008; 283: 21890-21898.
21. Hashemy SI, Johansson C, Berndt C, Lillig C, Holmgren A. Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: Effects on structure and activity. J Biol Chem 2007; 282: 14428-14436.
22. Winterbourn CC, Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 2008; 10: 1621-1630.
23. Chance B, Sies H, Boveris. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
24. Aikens J, Dix TA. Perhydroxyl radical (HOO.) initiated lipid peroxidation: The role of fatty acid hydroperoxides. J Biol Chem 1991; 266: 15091-15098.
25. Sugamura K, Keaney JF. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 2011; 51: 978-992.
26. Stone JR, Yang S. Hydrogen peroxide: A signaling messenger. Antiox Redox Signal 2006; 8: 243-270.
27. Deisseroth A, Dounce AL. Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 1970; 50: 319-375.
28. Baker LM, Raudonikiene A, Hoffman PS, Poole LB. Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: Genetic and kinetic characterization. J Bacteriol 2001; 183: 1961-1973.
29. Sugiyama T, Michel T. Thiol-metabolizing proteins and endothelial redox state: Differential modulation of eNOS and biopterin pathways. Am J Phsyiol Heart Circ Physiol 2010; 298: H194-H201.
30. Sugiyama T, Levy B, Michel T. Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide-synthase-dependent signaling pathways in cultured vascular endothelial cells. J Biol Chem 2009; 284: 12691-12700.
31. Maron BA, Zhang YY, Handy DE, Beuve A, Tang SS, Loscalzo J, et al. Aldosterone increases oxidant stress to impair soluble guanylyl cyclase by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem 2009; 284: 7665-7672.
32. Handy DE, Lubos E, Yang Y, Galbraith JD, Kelly N, Zhang YY, et al. Glutathione peroxidase-1 regulates mitochondrial function to modulate redox dependent cellular responses. J Biol Chem 2009; 284: 11913-11921.
33. Stacey MM, Vissers MC, Winterbourn CC. Oxidation of 2-cys peroxiredoxins in human endothelial cells by hydrogen peroxide, hypochlorous acid, and chloramines. Antioxid Redox Signal 2012; 17: 411-421.
34. Erwin PA, Lin AJ, Golan DE, Michel T. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2005; 280: 19888-19894.
35. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, et al. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation 2012; 126: 963-974.
36. 2 for safe signaling. Cell 2010; 140: 454-455.
37. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009; 458: 1056-1060.
38. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007; 104: 14855-14860.
39. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a highcalorie diet. Nature 2006; 444: 337-342.
40. D'Autréaux B, Toledano MB. ROS as signaling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813-824.
41. Piazza M, Futrega K, Spratt DE, Dieckmann T, Guillemette JG. Structure and dynamics of calmodulin (CaM) bound to nitric oxide synthase peptides: Effects of a phosphomimetic CaM mutation. Biochemistry 2012; 51: 3651-3661.
42. Kerwin JF Jr, Lancaster JR Jr, Feldman PL. Nitric oxide: A new paradigm for second messengers. J Med Chem 1995; 38: 4343-4362.
43. Lancaster JR. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 1994; 91: 8137-8141.
44. Schroder H, Noack E. Structure-activity relationship of organic nitrates for activation of guanylate cyclase. Arch Int Pharmacodyn Ther 1987; 290: 235-246.
45. Toledo JC, Augusto O. Connecting the chemical and biological properties of nitric oxide. Chem Res Toxicol 2012; 25: 975-989.
46. Hoffmann LS, Schmidt PM, Keim Y, Hoffmann C, Schmidt HH, Stasch JP. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells. PLoS One 2011; 6: e23596.
47. Thomson L, Trujillo M, Telleri R, Radi R. Kinetics of cytochrome c2+ oxidation by peroxynitrite: Implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys 1995; 319: 491-497.
48. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
49. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-879.
50. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, et al. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase-I-alpha. Science 1999; 286: 1583-1587.
51. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368: 850-853.
52. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187: 329-339.
53. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
54. Chamorro-Jorganes A, Calleros L, Griera M, Saura M, Luengo A, Rodriguez-Puyol D, et al. Fibronectin upregulates cGMP-dependent protein kinase Ibeta through C/EBP transcription factor activation in contractile cells. Am J Physiol Cell Physiol 2011; 300: C683-C691.
55. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009; 61: 22-32.
56. Harmon S, Inkielewicz-Stepniak I, Jones M, Ledwidge M, Santos-Martinez MJ, Medina C, et al. Mechanisms of aggregation inhibi tion by aspirin and nitrate-aspirin prodrugs in human platelets. J Pharm Pharmacol 2012; 64: 77-89.
57. Heller R, Bussolino F, Ghigo D, Garbarino G, Pescarmona G, Till U, et al. Nitrosovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochem Pharmacol 1992; 44: 223-229.
58. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 1995; 114: 1171-1178.
59. Liu S, Li Y, Kim S, Fu Q, Parikh D, Sridhar B, et al. Phosphodiesterase coordinates cAMP propogation induced by two stimulatory G protein-coupled receptors in hearts. Proc Natl Acad Sci USA 2012; 109: 6578-6583.
60. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 2005; 289: H701-H707.
61. Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 1985; 76: 703-708.
62. Sharpe MA, Cooper CE. Interaction of peroxynitrite with mitochondrial cytochrome oxidase: Catalytic production of nitric oxide and irreversible inhibition of enzyme activity. J Biol Chem 1998; 273: 30961-30972.
63. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
64. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 7674-7677.
65. Maron BA, Tang SS, Loscalzo J. S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal 2012 September 5 [Epub ahead of print].
66. Lundberg JO, Weitzberg E, Shiva S, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in mammals. In: Bryan NS, Loscalzo J, editors. Nitrite and nitrate in human health and disease. New York: Humana Press, 2011; 21-48.
67. Hermanson GT. The chemistry of reactive groups. In: Hermanson GT, editor. Bioconjugate techniques. London, Academic Press, 2008; 169.
68. Nedospasov A, Rafikov R, Beda N, Nudler E. An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci USA 2000; 97: 13543-13548.
69. Ramachandran N, Root P, Jiang XM, Hogg PJ, Mutus B. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci USA 2001; 98: 9539-9544.
70. Kurihara N, Alfie ME, Sigmon DH, Rhaleb NE, Shesely EG, Carretero OA. Role of nNOS in blood pressure regulation in eNOS null mutant mice. Hypertension 1998; 32: 856-861.
71. Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G, et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J Clin Invest 2011; 121: 120-131.
72. Ponnuswamy P, Schröttle A, Ostermeier E, Grüner S, Huang PL, Ertl G, et al. eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 2012; 7: e30193.
73. Maniatis NA, Shinin V, Schraufnagel DE, Okada S, Vogel SM, Malik AB, et al. Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/-mice. Am J Physiol Lung Cell Mol Physiol 2008; 294: L865-L873.
74. Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary nitrate on nitrite content of human saliva: Possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol 1976; 14: 545-548.
75. Crabtree MJ, Hale AB, Channon KM. Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency. Free Radic Biol Med 2011; 50: 1639-1646.
76. Berka V, Wu G, Yeh HC, Palmer G, Tsai AL. Three different oxygen-induced radical species in endothelial nitric-oxide synthase oxygenase domain under regulation by L-arginine and tetrahydrobiopterin. J Biol Chem 2004; 279: 32242-32251.
77. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T. Nitric oxide, Tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008; 10: 1115-1126.
78. Druhan JL, Forbes SP, Pope AJ, Chen CA, Zweier JL, Cardounel AJ. Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 2008; 27: 7256-7263.
79. Quijano C, Alvarez B, Gatti RM, Augusto O, Radi R. Pathways of peroxynitrite oxidation of thiol groups. Biochem J 1997; 322: 167-173.
80. Hofmann H, Schmidt HH. Thiol dependence of nitric oxide synthase. Biochemistry 1995; 34: 13443-13452.
81. Berka V, Wang LH, Tsai AL. Oxygen-induced radical intermediates in the nNOS oxygenase domain regulated by L-arginine, tetrahydrobiopterin, and thiol. Biochemistry 2008; 47: 405-420.
82. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010; 468: 1115-1118.
83. Chen CA, Lin CH, Druhan LJ, Wang TY, Chen YR, Zweier JL. Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation: A novel mechanism regulating eNOS function and coupling. J Biol Chem 2011; 286: 29098-29107.
84. Zweier JL, Chen CA, Druhan LJ. S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxid Redox Signal 2011; 14: 1769-1775.
85. Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, et al. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: Beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler Thromb Vasc Biol 2011; 31: 2223-2231.
86. Ravi K, Brennan LA, Levic S, Ross PA, Black SM. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci USA 2004; 101: 2619-2624.
87. Tummala M, Ryzhov V, Ravi K, Black SM. Identification of the cysteine nitrosylation sites in human endothelial nitric oxide synthase. DNA Cell Biol 2008; 27: 25-33.
88. Igarashi J, Li H, Jamal J, Fang J, Lawton GR, Silverman RB, et al. Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors. J Med Chem 2009; 52: 2060-2066.
89. Taldone FS, Tummala M, Goldstein EJ, Ryzhov V, Ravi K, Black SM. Studying the S-nitrosylation model of peptides and eNOS protein by mass spectrometry. Nitric Oxide 2005; 13: 176-187.
90. Kotsias F, Hoffmann E, Amigorena S, Savina A. Reactive oxygen species production in the phagosome: Impact on antigen presentation in dendritic cells. Antioxid Redox Signal 2012 September 11 [Epub ahead of print].
91. Montezano AC, Burger D, Paravicini TM, Chignalia AZ, Yusuf H, Almasri M, et al. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (NOX5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ Res 2010; 106: 1363-1373.
92. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007; 13: 189-197.
93. Burdon RH, Rice-Evans C. Free radicals and the regulation of mammalian cell proliferation. Free Radic Res Commun 1989; 6: 345-358.
94. Groeger G, Quiney C, Cotter TG. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 2009; 11: 2655-2671.
95. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000; 86: 347-354.
96. Sartoretto JL, Kalwa H, Pluth MD, Lippard SJ, Michel T. Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc Natl Acad Sci USA 2011; 108: 15792-15797.
97. Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, Kemp BE, et al. Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis 2008; 200: 28-36.
98. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono, Lee J, et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: Effects of vascular Tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 2006; 114: 1193-1201.
99. Patel HH, Insel PA. Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid Redox Signal 2009; 11: 1357-1372.
100. Sowa G, Pypaert M, Sessa WC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 2001; 98: 14072-14077.
101. Jin BY, Sartoretto JL, Gladyshev VN, Michel T. Endothelial nitric oxide synthase negatively regulates hydrogen peroxide-stimulated AMP-activated protein kinase in endothelial cells. Proc Natl Acad Sci USA 2009; 106: 17343-17348.
102. Tanaka T, Nakamura H, Yodoi J, Bloom ET. Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic Biol Med 2005; 38: 1231-1242.
103. Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, et al. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat Methods 2006; 3: 281-286.
104. Okamoto Y, Ninomiya H, Tanioka M, Sakamoto A, Miwa S, Masaki T. Palmitoylation of human endothelin-B: Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes. J Biol Chem 1997; 272: 21589-21596.
105. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993; 91: 1367-1373.
106. Maller C, Schröder E, Eaton P. Glyceraldehyde 3-phosphate dehydrogenase is unlikely to mediate hydrogen peroxide signaling: Studies with a novel anti-dimedone sulfenic acid antibody. Antioxid Redox Signal 2011; 14: 49-60.
107. Mastroberardino PG, Orr AL, Hu X, Na HM, Greenamyre JT. FRETbased method to study protein thiol oxidation in histological preparations. Free Radic Biol Med 2008; 45: 971-981.
108. Kou R, SenBanerjee S, Jain MK, Michel T. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: Interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling. Biochemistry 2005; 44: 15064-15073.
109. Savage DG, Antman KH. Imatinib mesylate: A new oral targeted therapy. N Engl J Med 2002; 346: 683-693.
110. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G, et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics. Mass Spectrom Rev 2005; 24: 55-99.
111. Edirisinghe I, Yang SR, Yao H, Rajendrasozhan S, Caito S, Adenuga D, et al. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J 2008; 22: 2297-2310.
112. Edirisinghe I, Arunachalam G, Wong C, Yao H, Rahman A, Phipps RP, et al. Cigarette-smoke-induced oxidative/nitrosative stress impairs VEGF-and fluid-shear-stress-mediated signaling in endothelial cells. Antioxid Redox Signal 2010; 12: 1355-1369.
113. Mathews MT, Berk BC. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler Thromb Vasc Biol 2008; 28: 711-717.
114. Hans CP, Feng Y, Naura AS, Zerfaoui M, Rezk BM, Xia H, et al. Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: Effects on eNOS and oxidative stress. PLoS One 2009; 4: e7430.
115. Koesling D. Studying the structure and regulation of soluble guanylyl cyclase. Methods 1999; 19: 485-493.
116. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, Meurer S, et al. Targeting the heme-oxidized nitric oxide receptor for selective vasodilation of diseased blood vessels. J Clin Invest 2006; 116: 2552-2561.
117. Warnholtz A, Mollnau H, Heitzer T, Kontush A, Möller-Bertram T, Lavall D, et al. Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. J Am Coll Cardiol 2002; 240: 1356-1363.
118. Ghofrani HA, Hoeper MM, Halank M, Meyer FJ, Staehler G, Behr J, et al. Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: A phase II study. Eur Respir J 2010; 36: 792-799.
119. Friebe A, Wedel B, Harteneck C, Foerster J, Schultz G, Koesling D. Functions of conserved cysteines of soluble guanylyl cyclase. Biochemistry 1997; 36: 1194-1198.
120. Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 2007; 104: 12312-12317.
121. Fernhoff NB, Derbyshire ER, Marletta MA. A nitric oxide/cysteine interaction mediates the activation of soluble guanylyl cyclase. Proc Natl Acad Sci USA 2009; 106: 21602-21607.
122. Rudyk O, Prysyazhna O, Burgoyne JR, Eaton P. Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1α knock-in mouse. Circulation 2012; 126: 287-295.
123. Sharma AK, Zhou GP, Kupferman J, Surks HK, Christensen EN, Chou JJ, et al. Probing the interaction between coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C terminus of the myosin binding subunit of the myosin light chain phosphatase. J Biol Chem 2008; 283: 32860-32869.
124. Burgoyne JR, Eaton P. Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to beta-adrenergic-like signaling. J Biol Chem 2009; 284: 29260-29268.
125. Brugoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schröder E, et al. Cysteine redox sensor in PKGIa enables oxidantinduced activation. Science 2007; 317: 1393-1397.
126. Stanton RC. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 2012; 64: 362-369.
127. Leopold JA, Zhang YY, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol 2003; 23: 411-417.
128. Leopold JA, Cap A, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 2001; 15: 1771-1773.
129. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2005; 102: 9056-9061.
130. Baehner RL, Nathan DG, Castle WB. Oxidant injury of Caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest 1971; 50: 2466-2473.
131. Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, et al. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 2004; 109: 898-903.
132. Dahoui HA, Hayek MN, Nietert PJ, Arabi MT, Muwakkit SA, Saab RH, et al. Pulmonary hypertension in children and young adults with sickle cell disease: Evidence for familial clustering. Pediatr Blood Cancer 2010; 54: 398-402.
133. Xu Y, Zhang Z, Hu J, Stillman IE, Leopold JA, Handy DE, et al. Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J 2010; 24: 609-616.
134. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011; 15: 1957-1997.
135. Flohe L, Günzler WA, Schock HH. Glutathione peroxidase: A selenoenzyme. FEBS Lett 1973; 32: 132-134.
136. Kraus RJ, Prohaska JR, Ganther HE. Oxidized forms of ovine erythrocyte glutathione peroxidase: Cyanide inhibition of a 4-glutathione: 4-selenoenzyme. Biochim Biophys Acta 1980; 615: 19-26.
137. Handy DE, Loscalzo J. Redox regulation of mitochondrial function. Antioxid Redox Signal 2012; 16: 1323-1367.
138. Singh AK, Dhaunsi GS, Gupta MP, Orak JK, Asayama K, Singh I. Demonstration of glutathione peroxidase in rat liver peroxisomes and its intraorganellar distribution. Arch Biochem Biophys 1984; 315: 331-338.
139. Utsunomiya H, Komatsu N, Yoshimura S, Tsutsumi Y, Watanabe K. Exact ultrastructural localization of glutathione peroxidase in normal rat hepatocytes: Advantages of microwave fixation. J Histochem Cytochem 1991; 39: 1167-1174.
140. Lubos E, Kelly NJ, Oldebeken SR, Leopold JA, Zhang YY, Loscalzo J, et al. Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cells activation. J Biol Chem 2011; 286: 35407-35417.
141. Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2002; 282: H1255-H1261.
142. Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: Abnormalities in vascular and cardiac function and structure. Circulation 2002; 106: 1154-1158.
143. Ulker S, McMaster D, McKeown PP, Bayraktutan U. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 2003; 59: 488-500.
144. Beigi F, Gonzalez DR, Minhas KM, Sun QA, Foster MW, Khan SA, et al. Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. Proc Natl Acad Sci USA 2012; 109: 4314-4319.
145. Gallogly MM, Starke DW, Mieyal JJ. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal 2009; 11: 1059-1081.
146. Becker K, Gui M, Schirmer RH. Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur J Biochem 1995; 234: 472-478.
147. Lee S, Kim SM, Lee RT. Thioredoxin and thioredoxin target proteins: From molecular mechanisms to functional significance. Antioxid Redox Signal 2012 June 26 [Epub ahead of print].
148. Hoffman J, Haendeler J, Aicher A, Rössig L, Vasa M, Zeiher AM, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: Important role of nitric oxide. Circ Res 2001; 89: 709-715.
149. Zai A, Rudd MA, Scribner AW, Loscalzo J. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest 1999; 103: 393-399.
150. Bell SE, Shah CM, Gordge MP. Protein disulfide-isomerase mediates delivery of nitric oxide redox derivatives into platelet. Biochem J 2007; 403: 283-288.
151. Pearce LL, Gandley RE, Han W, Wasserloos K, Stitt M, Kanai AJ, et al. Role of metallothionein in nitric oxide signaling as revealed by green fluorescent fusion protein. Proc Natl Acad Sci USA 2000; 97: 477-482.
152. 2+ and NO to form products with a g=2.039 ESR signal. Biochem Biophys Res Commmun 1993; 196: 632-635.
153. Zhou G, Lix X, Hein DW, Xiang X, Marshall JP, Prabhu SD, et al. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol 2008; 52: 655-666.
154. Schwartz MA, Lazo JS, Yalowich JC, Reynolds I, Kagan VE, Tyurin V, et al. Cytoplasmic metallothionein over-expression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J Biol Chem 1994; 269: 15238-15243.
155. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, et al. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 1995; 92: 4452-4456.
156. Li FY, Lam KS, Tse HF, Chen C, Wang Y, Vanhoutte PM, et al. Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice. Circulation 2012; 126: 1267-1277.
157. Durante W. Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front Biosci 2011; 16: 2372-2388.
158. Ryter SW, Si M, Lai CC, Su CY. Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. Am J Physiol Heart Circ Physiol 2000; 279: H2889-H2897.
159. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein peroxidation. J Biol Chem 1994; 269: 16712-16719.
160. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 1997; 80: 557-564.
161. Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, et al. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 2009; 119: 3017-3027.
162. Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris KG, McMurty IF. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002; 283: L346-L353.
163. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996; 270: H107-H114.
164. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, et al. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heat Circ Physiol 2007; 293: H3532-H3541.
165. Motterlini R, Foresti R, Bassi R, Calabrese V, Clarke JE, Green CJ. Endothelial heme oxygenase-1 induction by hypoxia: Modulation by inducible nitric oxide-synthase and S-nitrosothiols. J Biol Chem 2000; 275: 13613-13620.
166. Foresti R, Clark JE, Green CJ, Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: Involvement of superoxide and peroxynitrite anions. J Biol Chem 1997; 272: 18411-18417.
167. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-510.
168. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nature Chem Biol 2008; 4: 278-286.
169. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun 1993; 18: 195-199.
170. Gupta D, Harish B, Kissner R, Koppenol WH. Peroxynitrate is formed rapidly during decomposition of peroxynitrite at neutral pH. Dalton Trans 2009; 7: 5730-5736.
171. Gielis JF, Lin JY, Wingler K, Van Schil PE, Schmidt HH, Moens AL. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic Biol Med 2011; 50: 765-776.
172. Maron BA, Michel T. Nitric oxide: The vascular biology of nitric oxide and nitric oxide synthases. In: Marder VJ, Aird WC, Bennett JS, Schulman S, White GC, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Sixth Edition. Lippincott Williams & Wilkins (in press).